Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel

Summary

This randomized pilot clinical trial studies pregabalin in preventing acute pain syndrome in patients receiving paclitaxel. Pregabalin may control the pain caused by cancer treatment.

Timeline

Start

2012-01

Primary completion

2013-11

Completion

2016-04

Outcome

Missed primary endpoint

registry Arm I (Pregabalin) vs Arm II (Placebo); p = 0.56; Kruskal-Wallis NCT01637077 ↗

registry Arm I (Pregabalin) vs Arm II (Placebo); p = 0.48; Kruskal-Wallis NCT01637077 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pregabalin	Small molecule	—	Oral

Indications